TJP1 and ovarian carcinoma: In ovarian cancer, miR-146b inhibited the expression of F-box and leucine-rich repeat protein 10 (FBXL10) and also upregulated Cyclin D1, vimentin (VIM), and zona-occludens-1 (ZO-1) [53].